CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG ...
SAN FRANCISCO — Percutaneous coronary interventions (PCIs) have consistently been found to be less cost-effective than coronary artery bypass grafting (CABG) over the long term, but a new randomized ...
Elderly patients with complex geriatric conditions and left main or multivessel coronary artery disease who experience an acute coronary syndrome—particularly NSTEMI or unstable angina—fare ...
Nature Communications study reports an off-the-shelf bioengineered coronary conduit that remained patent for 18 months after anticoagulation was withdrawn, advancing a ready-to-use alternative for the ...
(UPDATED) In patients with ACS, performing CABG within a couple of days after ticagrelor cessation is noninferior to waiting 5 or 6 days in terms of bleeding events, according to new randomized data.
New findings question the need for oral anticoagulants for patients who develop atrial fibrillation (AF) after coronary artery bypass grafting (CABG), showing that while the arrythmia may be more ...
Women are significantly less likely than men to undergo coronary artery bypass grafting (CABG) using guideline-recommended approaches, which may result in worse outcomes after surgery, according to a ...
DUBLIN--(BUSINESS WIRE)--The "Coronary Artery Bypass Grafting (CABG) Devices Sector, Global, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This study provides a detailed ...
Please provide your email address to receive an email when new articles are posted on . In a real-world cohort of Medicare beneficiaries with ACS and multivessel CAD, CABG conferred lower odds of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results